Metformin Promotes Differentiation and Attenuates H2O2-Induced Oxidative Damage of Osteoblasts via the PI3K/AKT/Nrf2/HO-1 Pathway

At present, the drug treatment of osteoporosis is mostly focused on inhibiting osteoclastogenesis, which has relatively poor effects. Metformin is a drug that can potentially promote osteogenic differentiation and improve bone mass in postmenopausal women. We aimed to detect the molecular mechanism...

Full description

Saved in:
Bibliographic Details
Main Authors: Keda Yang (Author), Fangming Cao (Author), Shui Qiu (Author), Wen Jiang (Author), Lin Tao (Author), Yue Zhu (Author)
Format: Book
Published: Frontiers Media S.A., 2022-03-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!